MyAverix Finance
NS · Healthcare
Novelix Pharmaceuticals Ltd (536565)
Healthcare Services
Novelix Pharmaceuticals Ltd (536565) is listed on NS in the Healthcare sector. Industry: Healthcare Services. As of 2026-07-10, reported market cap is $1.69B, P/E ratio is 66.28, net margin is -0.3%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for 536565
Novelix Pharmaceuticals Ltd (536565) — FAQ
What is Novelix Pharmaceuticals Ltd's market cap?
Novelix Pharmaceuticals Ltd (536565) has a reported market cap of $1.69B (data as of 2026-07-10).
What is 536565's P/E ratio?
The price-to-earnings (P/E) ratio for Novelix Pharmaceuticals Ltd (536565) is 66.28 (data as of 2026-07-10).
Does Novelix Pharmaceuticals Ltd pay a dividend?
Dividend yield is not available in the current snapshot for Novelix Pharmaceuticals Ltd (536565). Check the MyAverix Finance app for the latest dividend data.
What sector is Novelix Pharmaceuticals Ltd in?
Novelix Pharmaceuticals Ltd (536565) is classified in the Healthcare sector (Healthcare Services industry).
What exchange is 536565 listed on?
536565 is listed on NS.
What is Novelix Pharmaceuticals Ltd's net margin?
Novelix Pharmaceuticals Ltd (536565) reports a net margin of -0.3% (data as of 2026-07-10).
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.